NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING
("Sativa" or "
We are pleased to announce that as part of
The clinic will be providing PCR testing for travel and work, antigen testing (results in 15 minutes) as well as antibody testing for those who want to find out if they have had COVID 19 and to see if they have developed antibodies.
Customers book an appointment online, and will attend in-store to self-administer the test guided by a trained medical professional. The company is already seeing strong demand in pre-bookings for this service.
The private clinic is designed for people who aren't presenting symptoms but who need a negative test for travel, work or peace of mind when visiting vulnerable relatives. Anyone with symptoms should instead book an
The PCR lab test is a swab sent for analysis at an accredited laboratory to test for the presence of COVID-19. A certificate delivered direct via email and SMS is provided to permit travelling and pass immigration. The test is 98% sensitive if the virus is found on the swab and has a 48-72-hour turnaround. The test cost
A rapid antigen test is also available, which checks whether you are carrying the COVID-19 virus and could be infectious to others. Sensitivity is 92.5% and Specificity is 99.8%. Results are available in 15 minutes and the test costs
Finally, an IgG and IgM rapid antibody test costing
For more information or to book an appointment visit https://www.goodbodyclinic.com
The Directors of the Company accept responsibility for the contents of this announcement.
Further information regarding the Company can be found at www.sedar.com.
On behalf of the Board of Directors,
Chief Executive Officer
+44 (0) 20 7971 1255
Chief Financial Officer
+44 (0) 20 7971 1255
Investor Relations and Communications
AQSE Growth Market Corporate Adviser
+ 44 (0) 20 7220 9795
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the